Can a K103N HIV strain stably overcome the wild type in the absence of non-nucleoside reverse transcriptase inhibitor selective pressure?
- 8 April 2005
- journal article
- other
- Published by Ovid Technologies (Wolters Kluwer Health) in AIDS
- Vol. 19 (6), 633-634
- https://doi.org/10.1097/01.aids.0000163943.31682.c8
Abstract
No abstract availableThis publication has 5 references indexed in Scilit:
- Characterization of Nevirapine Resistance Mutations in Women With Subtype A Vs. D HIV-1 6???8 Weeks After Single-Dose Nevirapine (HIVNET 012)JAIDS Journal of Acquired Immune Deficiency Syndromes, 2004
- Evolution of Human Immunodeficiency Virus Type 1 (HIV-1) Resistance Mutations in Nonnucleoside Reverse Transcriptase Inhibitors (NNRTIs) in HIV-1-Infected Patients Switched to Antiretroviral Therapy without NNRTIsAntimicrobial Agents and Chemotherapy, 2004
- Evolution of Lamivudine Resistance in Human Immunodeficiency Virus Type 1-Infected Individuals: the Relative Roles of Drift and SelectionJournal of Virology, 2000
- Patterns of Resistance and Cross-Resistance to Human Immunodeficiency Virus Type 1 Reverse Transcriptase Inhibitors in Patients Treated with the Nonnucleoside Reverse Transcriptase Inhibitor LovirideAntimicrobial Agents and Chemotherapy, 1998
- Prevalence and Clinical Significance of Zidovudine Resistance Mutations in Human Immunodeficiency Virus Isolated from Patients after Long-Term Zidovudine TreatmentThe Journal of Infectious Diseases, 1995